Atrial fibrillation is a heart rhythm disorder that causes the heart to beat irregularly, leading to potential health risks such as stroke.
The Mayo Clinic has pioneered a new treatment method called pulsed-field ablation, which has been approved by the FDA and shows promise over traditional methods.
This innovative treatment aims to minimize risks and improve outcomes for patients suffering from atrial fibrillation.